Financials

  • Market Capitalization 15.46 M
  • Employee 8
  • Founded 2013
  • CEO Murthy Simhambhatla
  • Website www.aeonbiopharma.com
  • Headquarter Delaware, United States
  • FIGI BBG00Z17HDW3
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4652
TPST
Tempest Therapeutics, Inc. - Common Stock
1.06 USD-1.85%+0.95%+19.10%-55.65%15.70 M USD
4653
HIND
Vyome Holdings, Inc. - Common Stock
2.21 USD0.00%+0.91%+7.80%-74.89%15.51 M USD
4658
NCEL
NewcelX Ltd. - Ordinary Shares
3.19 USD-6.73%-6.18%-8.33%-37.20%15.30 M USD
4660
LSTA
Lisata Therapeutics, Inc. - Common Stock
1.69 USD-7.14%+3.68%+56.48%-25.55%15.23 M USD

Frequently asked questions about AEON Biopharma, Inc.

What is the AEON Biopharma, Inc. stock price today?

The current price of AEON Biopharma, Inc. (AEON) is 0.31. Over the past 24 hours, the stock has changed by +6.90%. Follow the AEON chart for real-time price dynamics.

What is the stock ticker of AEON Biopharma, Inc.?

AEON Biopharma, Inc. trades under the ticker AEON. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is AEON Biopharma, Inc. stock going up?

AEON has changed by +55.00% over the last week, +24.00% over the last month, and -70.19% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of AEON Biopharma, Inc.?

AEON Biopharma, Inc. currently has a market capitalization of 15.46 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were AEON Biopharma, Inc. earnings last quarter?

Last quarter, AEON Biopharma, Inc. reported earnings of -0.02 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was AEON Biopharma, Inc. revenue for the last quarter?

AEON Biopharma, Inc. reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was AEON Biopharma, Inc. net income for the last quarter?

AEON Biopharma, Inc. reported net income of -1.16 M for the last quarter. The previous quarter showed -11.79 M, which means net income changed by +90.21%.

How many employees does AEON Biopharma, Inc. have?

As of the latest available data, AEON Biopharma, Inc. has 8 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy AEON Biopharma, Inc. stock?

You can buy AEON Biopharma, Inc. (AEON) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in AEON Biopharma, Inc. stock?

Investing in AEON Biopharma, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AEON chart and related analysis on metatrader.com as part of your research.

AEON Biopharma, Inc. Class A Common Stock

Alphaeon Corporation is a company focused on healthcare products and services based in Irvine, California. Alphaeon Corporation serves healthcare providers in the self-pay segment; primarily plastic surgery, ophthalmology, dentistry, and dermatology.

News